TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31120534

Group type: EXPERIMENTAL
Intervention: Black race in SEER cohort
Number of subjects: 306100

Group type: EXPERIMENTAL
Intervention: Black race in SEER cohort after IPW adjustment
Number of subjects: 306100

Group type: EXPERIMENTAL
Intervention: Black race in high-risk men in SEER cohort after IPW adjustment
Number of subjects: 306100

Group type: EXPERIMENTAL
Intervention: Black race in VA cohort after IPW adjustment
Number of subjects: 306100

Group type: EXPERIMENTAL
Intervention: Black race in RCT cohort after IPW adjustment
Number of subjects: 306100

Group type: EXPERIMENTAL
Intervention: Black race in SEER cohort for other-cause mortality (OCM)
Number of subjects: 306100

Group type: EXPERIMENTAL
Intervention: Black race in RCT cohort for OCM
Number of subjects: 306100
Study: 28531910

Group type: EXPERIMENTAL
Intervention: Intra-arterial treatment (IAT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intra-arterial treatment (Control)
Number of subjects: 0
Study: 25093677

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 24709264

Group type: EXPERIMENTAL
Intervention: Resiquimod 0.01% gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg orally twice daily for 5 days (RESI-VAL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral placebo (RESI-PLA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle and oral placebo (VEH-PLA)
Number of subjects: 0
Study: 22079954

Group type: EXPERIMENTAL
Intervention: Daily enteral zinc, selenium, glutamine, and intravenous metoclopramide (n = 149)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Daily enteral whey protein (n = 144)
Number of subjects: 293
Study: 19173752

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate NIV application to extubated patients at high risk for extubation failure
Number of subjects: 0

Group type: COMPARATOR
Intervention: NIV in heterogeneous patient populations
Number of subjects: 0

Group type: COMPARATOR
Intervention: NIV in case-control study
Number of subjects: 0
Study: 17074511

Group type: EXPERIMENTAL
Intervention: Fixed-flexion knee radiography
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Fixed-flexion knee radiography with satisfactory MTP alignment
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Fixed-flexion knee radiography with accurately reproduced IMD
Number of subjects: 193
Study: 15178151

Group type: EXPERIMENTAL
Intervention: Alpha‐lactalbumin supplement combined with carbohydrates (AS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Carbohydrates only (PS)
Number of subjects: 18
Study: 11771585

Group type: EXPERIMENTAL
Intervention: Ni‐Ti Pow‐R 0.04 ISO taper rotary files
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ni‐Ti ProFile 0.04 ISO taper rotary files
Number of subjects: 30
Study: 10099033

Group type: EXPERIMENTAL
Intervention: Delapril 30 mg + Indapamide 1.25 mg once daily for 24 weeks
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Delapril + Indapamide
Number of subjects: 28
Study: 1552469

Group type: EXPERIMENTAL
Intervention: Doxycycline plus metronidazole
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo plus metronidazole
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 2952046

Group type: EXPERIMENTAL
Intervention: Foscarnet 0.3% cream
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 30136644

Group type: COMPARATOR
Intervention: Information about local psychological services only (Control)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Information plus regular symptom monitoring (every 6 days)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Information plus open symptom monitoring (monitoring when they felt like it)
Number of subjects: 306
Study: 29626267

Group type: EXPERIMENTAL
Intervention: Ventilation strategy with FiO2 1.0
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ventilation strategy with EtCO2 40 mmHg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups at T6 (MAP back to baseline)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group with FiO2 0.4 and EtCO2 30 mmHg without PEEP
Number of subjects: 50
Study: 27091076

Group type: EXPERIMENTAL
Intervention: D4-MEHP (50μg/kg bw)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: D4-MnBP (10μg/kg bw)
Number of subjects: 4
Study: 24853311

Group type: COMPARATOR
Intervention: Adherence counseling intervention based on Lifesteps, an evidence-based HIV treatment adherence intervention; median number of sessions: 10.
Number of subjects: 1147
Study: 22330696

Group type: EXPERIMENTAL
Intervention: Docetaxel (75 mg/m(2)) and carboplatin (AUC 6) followed by irradiation to the involved field (50.4 Gy pelvis ± 43.5 Gy paraaortic) ± brachytherapy
Number of subjects: 45
Study: 20645945

Group type: EXPERIMENTAL
Intervention: Remifentanil 1.5 ng.ml(‐1)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (0 ng.ml(‐1) remifentanil)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Remifentanil 1.0 ng.ml(‐1)
Number of subjects: 104
Study: 17205281

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 12343

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 12343

Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 12343

Group type: EXPERIMENTAL
Intervention: Ondansetron 24 or 32 mg
Number of subjects: 12343

Group type: COMPARATOR
Intervention: Ondansetron higher doses (24 or 32 mg)
Number of subjects: 12343
Study: 16041629

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (200 microg every 12 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vaginal misoprostol (200 microg every 12 hours) + Isosorbide dinitrate (5 mg single dose)
Number of subjects: 0
Study: 11998910

Group type: EXPERIMENTAL
Intervention: DTaP vaccine
Number of subjects: 2924

Group type: EXPERIMENTAL
Intervention: DTP vaccine
Number of subjects: 2924

Group type: COMPARATOR
Intervention: DT vaccine
Number of subjects: 2924
Study: 9808824

Group type: EXPERIMENTAL
Intervention: Targeted communications campaign utilizing radio and television advertisements and community outreach
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no targeted communications campaign)
Number of subjects: 14
Study: 7579103

Group type: EXPERIMENTAL
Intervention: Alfentanil 50 micrograms/kg, propofol at 10 mg/kg/h, reduced to 1 microgram/kg/min after 4 min.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alfentanil 75 micrograms/kg, propofol at 10 mg/kg/h, reduced to 2 micrograms/kg/min after 4 min.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (Alfentanil 50 and 75 micrograms/kg)
Number of subjects: 30
Study: 2135712

Group type: EXPERIMENTAL
Intervention: Biperiden 2.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atropine 1.5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7001207

Group type: EXPERIMENTAL
Intervention: Guanfacine (3.3 mg daily)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Clonidine (0.5 mg daily)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 54

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 54
Study: 31543382

Group type: EXPERIMENTAL
Intervention: Intraoral group (n=30) using Trios Scanner, 3Shape
Number of subjects: 47

Group type: COMPARATOR
Intervention: Extraoral group (n=30) using D900L Lab Scanner, 3Shape
Number of subjects: 47
Study: 31374428

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 28292333

Group type: EXPERIMENTAL
Intervention: Hospital-based counselling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Field clinics or home visits counselling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counselling in hospital admission wards
Number of subjects: 0

Group type: COMPARATOR
Intervention: Information about risks and alternatives to PPIUD
Number of subjects: 0
Study: 26275705

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy plus cognitive‐coping therapy (pCCT)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Pharmacotherapy plus psychological support (PPS)
Number of subjects: 215
Study: 23467363

Group type: EXPERIMENTAL
Intervention: Transcranial electrical stimulation (TES) to the posterior parietal cortex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcranial electrical stimulation (TES) to the dorsolateral prefrontal cortex
Number of subjects: 0
Study: 21303262

Group type: EXPERIMENTAL
Intervention: LGNC-07 (1,680 mg for 16 weeks)
Number of subjects: 91

Group type: COMPARATOR
Intervention: LGNC-07 (single dose)
Number of subjects: 91
Study: 19843667

Group type: EXPERIMENTAL
Intervention: p16(INK4a) ELISA (enhanced version, >or=6 pg/mL cut-point)
Number of subjects: 1781

Group type: EXPERIMENTAL
Intervention: p16(INK4a) ELISA (original version, >or=8 pg/mL cut-point)
Number of subjects: 1781

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology
Number of subjects: 1781

Group type: EXPERIMENTAL
Intervention: Hybrid Capture II (hc2) testing
Number of subjects: 1781

Group type: EXPERIMENTAL
Intervention: p16(INK4a) ELISA (original version)
Number of subjects: 1781
Study: 16618908

Group type: EXPERIMENTAL
Intervention: SELDI‐TOF‐MS assay
Number of subjects: 78
Study: 14962398

Group type: EXPERIMENTAL
Intervention: Verbal prompts during task preparation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Task-compatible verbal prompts
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Task-incompatible verbal prompts
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Task-switching ability
Number of subjects: 3
Study: 11343529

Group type: EXPERIMENTAL
Intervention: Sertraline (50 to 200 mg daily for 12 weeks)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 9392394

Group type: EXPERIMENTAL
Intervention: Lispro insulin injected immediately before breakfast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular insulin injected 20 min preprandially
Number of subjects: 0
Study: 7516978

Group type: EXPERIMENTAL
Intervention: Leuprolide 3.75 mg depot injection every 28 days for 24 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 2597713

Group type: EXPERIMENTAL
Intervention: EMG biofeedback from the forearm extensor and frontalis muscles
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Progressive relaxation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EMG biofeedback
Number of subjects: 30
Study: 5667992

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate
Number of subjects: 8
Study: 30859848

Group type: EXPERIMENTAL
Intervention: 15 g of vitamin C-enriched gelatin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 15 g of hydrolyzed collagen (HC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Gummy containing equal parts of gelatin and HC
Number of subjects: 10
Study: 29258549

Group type: EXPERIMENTAL
Intervention: Home-based nutritional counselling by trained Community Health Workers (CHWs) during scheduled visits; specific maternal infant and young child nutrition (MIYCN) messages provided.
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Control group received standard care from untrained CHWs.
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Intervention arm (Home-based nutritional counselling) vs Control arm (Standard care)
Number of subjects: 1110
Study: 26028449

Group type: EXPERIMENTAL
Intervention: Interactive seminar and training of practice nurses
Number of subjects: 313

Group type: COMPARATOR
Intervention: Interactive seminar without further intervention
Number of subjects: 313

Group type: COMPARATOR
Intervention: E-learning
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Combination of interactive seminar and training of practice nurses
Number of subjects: 313

Group type: COMPARATOR
Intervention: Practice nurses without continuing medical education
Number of subjects: 313
Study: 23550861

Group type: EXPERIMENTAL
Intervention: Omega-3 (1,500 mg daily for 6 months)
Number of subjects: 45
Study: 21324167

Group type: EXPERIMENTAL
Intervention: Scaling and root planning plus local delivered chlorhexidine
Number of subjects: 98

Group type: COMPARATOR
Intervention: Supragingival plaque removal only
Number of subjects: 98
Study: 19253801

Group type: EXPERIMENTAL
Intervention: Castor oil
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sodium phosphate preparation
Number of subjects: 100
Study: 16777857

Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 128

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 128
Study: 15141520

Group type: EXPERIMENTAL
Intervention: Atosiban for 18 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fenoterol for 18 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hexoprenalin for 18 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atosiban for 48 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fenoterol for 48 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hexoprenalin for 48 hours
Number of subjects: 0
Study: 21225849

Group type: EXPERIMENTAL
Intervention: Intravenous injection of 0.46 mg/kg dose of cocaine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 9159038

Group type: EXPERIMENTAL
Intervention: Serum sHLA-I concentrations in patients with HFRS
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Serum sHLA-I concentrations in patients with hypotensive episodes
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Serum sHLA-I levels correlation with blood WBC count
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Serum sHLA-I levels correlation with serum creatinine concentrations
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Urine sHLA-I levels in oliguric phase
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Persistent elevation of serum sHLA-I
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Serum and urine sHLA-I concentrations
Number of subjects: 22
Study: 7667717

Group type: EXPERIMENTAL
Intervention: 5-day regimen (300 mg initial dose followed by 100 mg for another 4 days)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 7-day regimen (160 mg initial dose followed by 80 mg daily for another 6 days)
Number of subjects: 28
Study: 3498403

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Methohexitone
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (Propofol vs Methohexitone)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study: 29745804

Group type: EXPERIMENTAL
Intervention: 1,000 µg salbutamol (SAL)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 11
Study: 26971242

Group type: EXPERIMENTAL
Intervention: Tiotropium HandiHaler®
Number of subjects: 921

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study: 25564322

Group type: EXPERIMENTAL
Intervention: Daikenchuto (DKT) 7.5 g/day, t.i.d. for 3 months
Number of subjects: 81

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 81
Study: 23622445

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 35

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 35
Study: 21320967

Group type: EXPERIMENTAL
Intervention: Sham treatment
Number of subjects: 238

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 238
Study: 18715742

Group type: EXPERIMENTAL
Intervention: Adolescent Community Reinforcement Approach (A‐CRA)
Number of subjects: 399
Study: 16429299

Group type: EXPERIMENTAL
Intervention: Isotretinoin 0.8 mg/kg for 4 weeks
Number of subjects: 10
Study: 15143418

Group type: EXPERIMENTAL
Intervention: Salbutamol (200 micro g)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ipratropium bromide (36 micro g)
Number of subjects: 25
Study: 10617706

Group type: EXPERIMENTAL
Intervention: NIDCAP
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 25
Study: 8812752

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) 333.3 ng/min
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Iloprost 41.7 ng/min
Number of subjects: 18

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 18
Study: 1615182

Group type: EXPERIMENTAL
Intervention: Amoxy 500 mg plus bromhexeine 8 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain amoxy 500 mg
Number of subjects: 0
Study: 6389377

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg) after fasting
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg) with antacid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg) after a meal
Number of subjects: 10
Study: 30262436

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 28952218

Group type: EXPERIMENTAL
Intervention: Javanica oil emulsion injection (JOEI) combined with radiotherapy (RT)
Number of subjects: 1269
Study: 27155958

Group type: EXPERIMENTAL
Intervention: Individually tailored online intervention
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Summary Report Phase
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: MI consistent techniques
Number of subjects: 527
Study: 25127208

Group type: EXPERIMENTAL
Intervention: 20 mg ponesimod
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: 40 mg ponesimod
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: 20 mg ponesimod (maintenance)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: 40 mg ponesimod (maintenance)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo (swapped from 20 mg)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo (swapped from 40 mg)
Number of subjects: 326
Study: 22397386

Group type: EXPERIMENTAL
Intervention: Self-ligating brackets (SL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional edgewise twin brackets (CE)
Number of subjects: 100
Study: 19773048

Group type: EXPERIMENTAL
Intervention: Mini-incision carpal tunnel release (CTR) with <2 cm incision using KnifeLight instrument
Number of subjects: 185

Group type: COMPARATOR
Intervention: Limited open technique (3-4 cm incision)
Number of subjects: 185
Study: 17290061

Group type: EXPERIMENTAL
Intervention: Ifosfamide 1.6 g/m2 IV daily for 3 days plus paclitaxel 135 mg/m2 by 3‐hour infusion on day 1 (arm 2)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Ifosfamide 2.0 g/m2 IV daily for 3 days (arm 1)
Number of subjects: 179
Study: 15458510

Group type: EXPERIMENTAL
Intervention: Combined treatment (chemo and radiotherapy)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Educational status
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Income
Number of subjects: 218

Group type: COMPARATOR
Intervention: Highest vs. lowest education group
Number of subjects: 218

Group type: COMPARATOR
Intervention: Highest vs. lowest income group
Number of subjects: 218
Study: 11471084

Group type: EXPERIMENTAL
Intervention: Health, water and hygiene programmes initiated in the past 16 years
Number of subjects: 2744
Study: 9580354

Group type: EXPERIMENTAL
Intervention: Psychoeducational groups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychoeducational groups (first episode patients)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (first episode patients)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychoeducational groups (patients with previous history)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (patients with previous history)
Number of subjects: 0
Study: 7519979

Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms in 10 mL of saline)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Synthetic porcine galanin (500 micrograms in 100 mL of saline)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Clonidine + synthetic porcine galanin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 13
Study: 3287815

Group type: EXPERIMENTAL
Intervention: 1 g metronidazole
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 3 g metronidazole
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 1 g metronidazole + 3 g nalidixic acid
Number of subjects: 103

Group type: COMPARATOR
Intervention: 1 g metronidazole (3-4 hours preoperatively)
Number of subjects: 103
Study: 31391069

Group type: EXPERIMENTAL
Intervention: Impact of Event Scale-6 (IES-6)
Number of subjects: 1001
Study: 28549439

Group type: EXPERIMENTAL
Intervention: Abdominal aortic balloon occlusion (AABO) in combination with cesarean section
Number of subjects: 170

Group type: COMPARATOR
Intervention: Traditional hysterectomy following cesarean section
Number of subjects: 170
Study: 25602581

Group type: EXPERIMENTAL
Intervention: ERPonline web-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 23620949

Group type: EXPERIMENTAL
Intervention: 2 Hz/100 Hz EA treatment group (group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2 Hz EA treatment group (group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 100 Hz EA treatment group (group C)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (group D)
Number of subjects: 120
Study: 20731584

Group type: EXPERIMENTAL
Intervention: Bone grafting with a xenograft (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No grafting material (Group B)
Number of subjects: 100
Study: 17964223

Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 1036

Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 1036
Study: 16939905

Group type: EXPERIMENTAL
Intervention: Tazarotene treatment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 12671829

Group type: EXPERIMENTAL
Intervention: Oral calcitriol pulse therapy (twice weekly for 3 months)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (twice weekly for 3 months)
Number of subjects: 48